unknown
Stage
About
enableCV develops perfusion devices that maintain continuous blood flow during cardiac surgery, supporting both traditional open-heart and minimally invasive procedures. The company supplies hospitals globally (600+ institutions across 30+ countries) and partnered with Water Street Healthcare Partners in 2025 to accelerate product development and expand its footprint.
Explore enableCV's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.